Masimo (MASI) Current Deferred Revenue (2010 - 2026)
Masimo's (MASI) quarterly Current Deferred Revenue came in at $70.2 million in Q2 2026, down 3.31% year-on-year from $72.6 million in Q2 2025, and down 4.1% quarter-over-quarter from $73.2 million in Q1 2026.
Masimo (MASI) Current Deferred Revenue (2010 - 2026) Analysis & Trends
Masimo's Current Deferred Revenue history runs 17 years deep, the most recent figure standing at $70.2 million for Q2 2026.
- On a quarterly basis, Current Deferred Revenue fell 3.31% year-over-year to $70.2 million in Q2 2026; TTM through Apr 2026 was $70.2 million, a 3.31% decrease from a year earlier, with the FY2026 full-year figure at $73.2 million, down 4.81% from the prior year.
- Current Deferred Revenue declined to $70.2 million in Q2 2026 per MASI's latest filing, from $73.2 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $87.3 million in Q4 2023 and bottomed at $48.7 million in Q2 2022.
- The 5-year median for Current Deferred Revenue is $74.6 million (2022), against an average of $73.3 million.
- Across the five-year window, Current Deferred Revenue jumped 127.57% in 2022 and fell 19.05% in 2025, its largest moves.
- Year by year, Current Deferred Revenue stood at $80.6 million in 2022, then gained by 8.31% to $87.3 million in 2023, then dropped by 11.91% to $76.9 million in 2024, then dropped by 11.05% to $68.4 million in 2025, then advanced by 2.63% to $70.2 million in 2026.
- Per Business Quant, the three latest MASI Current Deferred Revenue figures stand at $70.2 million (Q2 2026), $73.2 million (Q1 2026), and $68.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 70.20 Mn |
| Jan 3, 2026 | 73.20 Mn |
| Sep 27, 2025 | 68.40 Mn |
| Jun 28, 2025 | 75.40 Mn |
| Mar 29, 2025 | 72.60 Mn |
| Dec 28, 2024 | 76.90 Mn |
| Sep 28, 2024 | 84.50 Mn |
| Jun 29, 2024 | 79.80 Mn |
| Mar 30, 2024 | 70.00 Mn |
| Dec 30, 2023 | 87.30 Mn |
| Sep 30, 2023 | 73.10 Mn |
| Jul 1, 2023 | 73.70 Mn |
| Apr 1, 2023 | 81.70 Mn |
| Dec 31, 2022 | 80.60 Mn |
| Oct 1, 2022 | 77.60 Mn |
| Jul 2, 2022 | 75.40 Mn |
| Apr 2, 2022 | 48.74 Mn |
| Jan 1, 2022 | 50.90 Mn |
| Oct 2, 2021 | 34.39 Mn |
| Jul 3, 2021 | 33.13 Mn |